2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
0 hedge funds and large institutions have $0 invested in 2seventy bio in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $508K → $0 (-$508K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$466K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$42.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
N
1
Nuveen
Charlotte,
North Carolina
| – | -$466K | -93,115 | Closed |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| – | -$42.4K | -2,857 | Closed |
|
TSVT Hedge Fund Activity: Q3 2025 in Review
0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q3 2025, worth a combined $0 — down 100% from $508K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TSVT and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Nuveen, exiting entirely with an estimated $466K sold.
- 0 institutional investors held 2seventy bio (TSVT) as of Q3 2025, down from 2 in Q2 2025.
- Funds reported $0 of 2seventy bio stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new 2seventy bio positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest 2seventy bio seller in Q3 2025 was Nuveen, an estimated $466K sold.
Based on aggregated 13F filings for Q3 2025.